19 insiders reported 59 Form 4 transactions for Evommune, Inc. (EVMN) over the past 18 months (most recent 2026-07-10). Recent activity: Carver Kyle (Chief Financial Officer) Buy 1,000 shares, KIRSCH ARTHUR S (Director) Buy 10,000 shares, Pena Luis C. (President & CEO) Sell 7,438 shares, Drew Janice Suzann (Chief of Dev. Operations) Buy 3,839 shares, Patel Jeegar Pravinkumar (Chief Scientific Officer) Buy 1,488 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Carver Kyle | Chief Financial Officer | Buy | 1,000 | $13,260 |
| 2026-07-08 | KIRSCH ARTHUR S | Director | Buy | 10,000 | $133,000 |
| 2026-06-24 | Pena Luis C. | President & CEO | Sell | 7,438 | $168,917 |
| 2026-06-24 | Drew Janice Suzann | Chief of Dev. Operations | Buy | 3,839 | $14,742 |
| 2026-06-24 | Patel Jeegar Pravinkumar | Chief Scientific Officer | Buy | 1,488 | $5,714 |
| 2026-06-24 | Drew Janice Suzann | Chief of Dev. Operations | Buy | 16,161 | $48,321 |
| 2026-06-24 | Patel Jeegar Pravinkumar | Chief Scientific Officer | Sell | 1,488 | $33,480 |
| 2026-06-24 | Drew Janice Suzann | Chief of Dev. Operations | Sell | 20,000 | $452,600 |
| 2026-06-03 | Patel Jeegar Pravinkumar | Chief Scientific Officer | Sell | 16,687 | $379,462 |
| 2026-06-03 | Pena Luis C. | President & CEO | Sell | 16,787 | $381,736 |
| 2026-06-03 | Patel Jeegar Pravinkumar | Chief Scientific Officer | Buy | 13,512 | $51,886 |
| 2026-06-03 | Cohen David E | Director | Sell | 600 | $12,828 |
| 2026-06-03 | Cohen David E | Director | Sell | 5,456 | $110,266 |
| 2026-06-01 | Carver Kyle | Chief Financial Officer | Buy | 15,000 | $44,850 |
| 2026-06-01 | Moss Gregory S. | Chief Business & Legal Officer | Buy | 14,223 | $24,321 |
| 2026-06-01 | Moss Gregory S. | Chief Business & Legal Officer | Sell | 14,223 | $324,711 |
| 2026-06-01 | Carver Kyle | Chief Financial Officer | Sell | 18,175 | $415,117 |
| 2026-02-19 | LSP 7 Cooperative UA | Director | Buy | 358,680 | $10.0M |
| 2026-02-18 | Verduyn-van Weegen Felice Isabel | Director | Buy | 358,680 | $10.0M |
| 2026-02-17 | RA Capital Healthcare Fund LP | Director | Buy | 35,868 | $1,000,000 |
| 2026-02-17 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 35,868 | $1,000,000 |
| 2026-02-17 | Kolchinsky Peter | Director | Buy | 35,868 | $1,000,000 |
| 2026-02-17 | Shah Rajeev M. | Director | Buy | 35,868 | $1,000,000 |
| 2026-02-17 | RA Capital Nexus Fund III, L.P. | Director | Buy | 35,868 | $1,000,000 |
| 2025-12-22 | Hopfner Robert Lorne | Director | Buy | 1,000 | $17,350 |
Source: SEC Form 4 filings · as of 2026-07-10